CAN FITE BIOFARMA LTD's ticker is CANF and the CUSIP is 13471N201. A total of 13 filers reported holding CAN FITE BIOFARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $186,766 | -24.4% | 304,675 | -4.8% | 0.00% | – |
| Q3 2022 | $247,000 | -20.6% | 320,175 | -5.4% | 0.00% | – |
| Q2 2022 | $311,000 | -17.5% | 338,275 | +11.2% | 0.00% | – |
| Q1 2022 | $377,000 | +22.4% | 304,175 | +27.6% | 0.00% | – |
| Q4 2021 | $308,000 | -5.5% | 238,455 | +21.2% | 0.00% | – |
| Q3 2021 | $326,000 | -22.6% | 196,675 | +6.4% | 0.00% | – |
| Q2 2021 | $421,000 | +113.7% | 184,775 | +131.3% | 0.00% | – |
| Q1 2021 | $197,000 | +535.5% | 79,873 | +351.9% | 0.00% | – |
| Q4 2020 | $31,000 | +244.4% | 17,676 | +257.6% | 0.00% | – |
| Q3 2020 | $9,000 | +12.5% | 4,943 | +27.7% | 0.00% | – |
| Q2 2020 | $8,000 | -38.5% | 3,870 | -61.8% | 0.00% | – |
| Q1 2020 | $13,000 | -87.0% | 10,119 | -66.8% | 0.00% | – |
| Q4 2019 | $100,000 | -3.8% | 30,439 | -39.8% | 0.00% | – |
| Q3 2019 | $104,000 | -40.9% | 50,540 | -17.1% | 0.00% | – |
| Q2 2019 | $176,000 | – | 60,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UBS Group AG | 7,181 | $9,000 | 0.00% |
| FIFTH THIRD BANCORP | 30,000 | $37,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 366 | $0 | 0.00% |
| STIFEL FINANCIAL CORP | 12,000 | $15,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,500 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| CITIGROUP INC | 5,535 | $7,000 | 0.00% |
| MORGAN STANLEY | 304,175 | $377,000 | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 6,000 | $7,000 | 0.00% |
| Citadel Advisors | 11,333 | $14,000 | 0.00% |